Concanavalin A—induced liver cell damage: Activation of intracellular pathways triggered by tumor necrosis factor in mice☆☆☆ by Trautwein, C. et al.
Concanavalin A–Induced Liver Cell Damage: Activation
of Intracellular Pathways Triggered by Tumor
Necrosis Factor in Mice
CHRISTIAN TRAUTWEIN,* TIM RAKEMANN,* DAVID A. BRENNER,‡
KONRAD STREETZ,* LAURA LICATO,‡ MICHAEL P. MANNS,* and GISA TIEGS§
*Department of Gastroenterology and Hepatology, Medizinische Hochschule Hannover, Hannover, Germany; ‡Department of Gastroenterology
and Hepatology, University of North Carolina, Chapel Hill, North Carolina; and §Institute of Experimental and Clinical Pharmacology
and Toxicology, University of Erlangen, Erlangen, Germany
Background & Aims: Concanavalin A (con A) induces
tumor necrosis factor (TNF)-dependent hepatocyte
apoptosis resembling immune-mediated fulminant he-
patic failure in humans. Intracellular pathways originat-
ing at the TNF receptor are either linked to apoptosis,
nuclear factor (NF)-kB translocation, or Jun kinase
(JNK) activation. The aim of this study was to study
TNF-dependent pathways after con A injection in vivo.
Methods: Con A, con A plus anti-TNF, and control buffer
were injected into BALB/c mice. Immunofluorescence,
Western blot, Northern blot, gel shift, Erk, and JNK
activity and DNA fragmentation experiments were per-
formed at different time points after injection. Results:
DNA fragmentation in hepatocytes was increased 4–24
hours after con A injection. JNK was activated maxi-
mally (G20-fold) directly after con A injection, whereas
binding and nuclear translocation of NF-kB was maxi-
mal after 4 hours. All pathways were blocked by
anti-TNF. JNK activation was specific because related
ERK 1 1 2 were not activated after con A. High nuclear
expression of c-Jun was already evident 1 hour after
con A injection; however, in contrast to JNK, anti-TNF
treatment did not block c-Jun nuclear expression and
DNA binding. Conclusions: In the con A model, activa-
tion of TNF-dependent pathways is associated with
apoptosis of hepatocytes. Their modulation in vivo may
have implications to develop new therapeutic strate-
gies to prevent apoptosis.
Fulminant hepatic failure due to viral infection,intoxication, or other causes is a life-threatening
event. Immune-mediated mechanisms that ultimately
lead to apoptosis of hepatocytes are frequently involved in
this process.1 Therefore, animal models that mimic the
condition of immune-dependent hepatocyte cell death are
important to understand the mechanisms leading to liver
failure and to develop new therapeutic approaches that
may also be important in humans.
A new animal model of immune-mediated liver injury
was developed2 in which concanavalin A (con A) injection
into mice leads to dose-dependent apoptosis of hepato-
cytes.3,4 Con A has high affinity toward the hepatic sinus,
leading to T-cell activation in the liver.3,5 A subset of T
lymphocytes, the CD4-positive cells, are activated as
anti-CD4 antibodies block activation, and consequently,
liver cell death.2 In addition to the activated T lympho-
cytes, polymorphonuclear cells are found in the infil-
trated liver, possibly recruited by CD4-positive cells.5
The assembly of immune-activated cells in the liver
results in increased levels of several cytokines involved in
cell to cell communication and inflammation. High
levels of the cytokines interleukin (IL)-2, tumor necrosis
factor (TNF)-a, IL-6, granulocyte-macrophage colony–
stimulating factor, and IL-1 were found after con A
injection, showing a time-dependent release into the
plasma.2,3,5 Because high circulating TNF levels were
found early after con A injection, blocking experiments
with anti-TNF antibodies were performed. Interestingly,
anti-TNF completely blocked liver cell injury, indicating
that TNF plays a major role in mediating apoptosis of
hepatocytes in this model.3,5
Activation of several cell surface receptors can mediate
apoptosis. The TNF receptor 1 belongs to the TNF/nerve
growth factor receptor family and has a so-called death
domain in the cytoplasmic part of the receptor.6,7 Bind-
ing of TNF to TNF receptor 1 activates diverse intracellu-
lar pathways. Besides its capacity to induce apoptosis,
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other pathways that lead to nuclear factor (NF)-kB and
Jun kinase ( JNK) activation have been characterized
recently in more detail.8–11 These experiments showed
that the signal cascades that either activate NF-kB, JNK,
or apoptosis directly diverge at the inner cell membrane.
TRADD, which binds to the cytoplasmic domain of TNF
receptor 1, is important for the activation of all of these
pathways.8,11 On TNF receptor activation, three proteins,
FADD/MORT1, TRAF2, and RIP, are capable of binding
TRADD (TNF receptor 1–associated death domain pro-
tein). TRAF2 and RIP are important in activating
downstream events leading to nuclear translocation of
NF-kB and JNK activation, whereas FADD (Fas-
associated death domain protein)/MORT1 mediates essen-
tial signals for the induction of apoptosis involving
interleukin-converting enzyme proteases.8–12 The TNF
receptor 2, which also binds TNF-a, can only activate
TRAF2-dependent signals but not FADD-dependent
apoptosis.13
So far the activation of TNF-dependent pathways has
been mainly investigated by in vitro studies.8–10 In vivo
results showing the importance of these pathways in
animal models are lacking. Because apoptosis of hepato-
cytes in the con A model is mediated by TNF-a,3,5 we
were interested in studying whether these pathways are
also involved in this process in vivo. Therefore, these
cascades were investigated after con A injection and after
pretreatment with anti-TNF antibodies. JNK, NF-kB,
and apoptosis become activated during con A–induced
apoptosis in a TNF-dependent fashion. Differences in the
time courses of these pathways show that NF-kB and
JNK are not necessary to maintain apoptosis. Because the
balance between the different pathways that diverge at
the TNF receptor dissect between apoptotic and antiapop-
totic mechanisms, this in vivo model has implications for
developing strategies that prevent apoptosis in vivo.
Materials and Methods
Animals, Con A Injection, and Preparation
of Liver Nuclear Extracts
Pathogen-free male BALB/c mice were obtained from
the Animal Research Institute of the Medizinische Hochschule
Hannover. All experiments were started between 8 AM and 10
AM and were performed in agreement with the German legal
requirements. Animals were anesthetized by an intraperitoneal
injection of a combination of xylazine and ketamine hydrochlo-
ride as described previously.14 At least 4 animals were treated in
parallel for each time point.
Con A (20 mg/kg) was injected intravenously. Anti-TNF
immunoglobulin (Ig) was administered 15 minutes before con
A injection when indicated.2,3 In control-treated animals, only
the carrier solution, phosphate-buffered saline, was injected. At
the indicated time points, a small subxiphoid incision was
made, blood samples were taken, and the liver was removed.
The livers from animals treated in parallel were pooled. A part
of the liver was frozen for Northern blot analysis, immunofluo-
rescence, and DNA fragmentation assays. The remaining liver
was used to prepare liver nuclear extracts.
For preparation of nuclear extracts, the pooled livers were
rinsed in ice-cold phosphate-buffered saline and liver nuclear
proteins were prepared as described previously.14 All steps were
performed at 4°C. Nuclear proteins were aliquoted and
immediately frozen in liquid nitrogen.
Sodium Dodecyl Sulfate–Polyacrylamide
Gel Electrophoresis and Western Blot
Analysis
Sodium dodecyl sulfate–polyacrylamide gel electropho-
resis (SDS-PAGE) and Western blot analysis with liver nuclear
proteins were performed as described.15 Antibodies for NF-kB
and c-Jun proteins were purchased from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA).
Gel Retardation Assays
Gel retardation assays with liver nuclear extracts were
performed with consensus oligonucleotides for c-Jun (58-CGC-
TTG-ATG-ACT-CAG-CCG-GAA-38) or NF-kB site (58-TAG-
TTG-AGG-GGA-CTT-TCC-CAG-GCA-38) as described pre-
viously.16 Supershift experiments were performed with either
an antibody directed against c-Jun or NF-kB (Santa Cruz
Biotechnology).
Northern Blot Analysis
Northern blot analysis was performed according to
standard procedures, as described previously.14 c-Jun and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) comple-
mentary DNA probes were labeled with [a-32P]adenosine-
triphosphate (ATP) according to Rediprime (Amersham, Braun-
scheig, Germany). The hybridization procedure was performed
as described previously.14
Immunofluorescence
For immunofluorescence experiments, cryosections (4–5
µm thick) were performed and immediately fixed in ice-cold
acetone for 5 minutes, air-dried, and either stored at 280°C or
used immediately. Immunofluorescence staining was performed
essentially as described previously.17 Anti–NF-kB (Santa Cruz
Biotechnology) and anti–cytochrome P450 2D6 were both
incubated as primary antibodies. Anti-rabbit IgG Cy3–
conjugated antibodies (Sigma Chemical Co., St. Louis, MO)
and anti-human fluorescein isothiocyanate (FITC)-conjugated
antibodies (Dianova, Hamburg, Germany) were used as second-
ary antibodies. Sections were analyzed through either a 615-nm
filter (Cy3 staining) or a 525-nm filter (FITC staining) with an
Olympus fluorescence microscope (Hamburg, Germany).
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In Vitro Kinase Assays
JNK activity was assessed by an in vitro kinase assay as
described previously18 using recombinant glutathione S-
transferase (GST)-c-Jun protein (1–79). The proteins were
fractionated using 12.5% SDS-PAGE and visualized and
quantitated using Fujix Bas 1000 Bioimaging Analyser (Ray-
test, Straubenhardtf, Germany). Coomassie staining was used
to show equal protein loading.
ERK activity was assessed similarly using an in vitro
immune complex kinase assay with recombinant GST-Elk
protein as a substrate. Immunoprecipitation was performed on
whole-cell extracts using an anti–ERK-2 antibody (Santa Cruz,
C14; cross-reactive with ERK-1). The proteins were fraction-
ated using 12.5% SDS-PAGE and visualized and quantitated
using PhosphorImager analysis. Coomassie staining was used
to demonstrate equal protein loading.
DNA Fragmentation
For determination of DNA fragmentation by enzyme-
linked immunosorbent assay (ELISA), one liver lobe (20%) was
treated in TE buffer with five strokes of a homogenizer (pestle
B). The 20% homogenate was centrifuged at 13,000g for 20
minutes. The supernatant was further diluted 200-fold and
directly used to determine DNA fragmentation by the commer-
cially available ELISA system cell death detection (Boehringer
Mannheim) according to the manufacturer’s instructions, de-
signed to quantify cytosolic oligonucleosome-bound DNA
(histone ELISA). The level of DNA fragmentation found before
treatment was set to 1, and changes were shown as fold
activation.
Immunohistochemical detection of apoptosis was performed
using the in situ cell death detection kit (terminal deoxynucleo-
tidyl transferase–mediated deoxyuridine triphosphate nick-end
labeling [TUNEL] Test; Boehringer Mannheim). Fixation of
the cells was performed with acetone instead of paraformalde-
hyde. All other steps were performed according to manufactur-
er’s instructions. The fluorescence-labeled DNA fragments
were analyzed using an immunofluorescence microscope (Olym-
pus IMT2-BH2; Tokyo).
Quantification
Quantification of results was performed with a Fujix
Bas 1000 Bioimaging Analyser (Raytest) or by a densitometer
as described before.14
Results
Con A Injection Induces Time-Dependent
Apoptosis of Liver Cells
To test the time course of T cell–mediated
apoptosis after con A injection, DNA fragmentation was
measured in the liver at different time points after
injection in comparison to the pretreatment status. By
histone ELISA, DNA fragmentation started as early as 4
hours after con A injection (Figure 1A). The increase after
4 hours was .40% of background level. Maximal
increase occurred after 8 hours, exceeding the pretreat-
ment level more than sixfold. High cytosolic DNA
fragmentation was monitored for up to 24 hours after
treatment; the amount of DNA fragmentation was
reduced after 48 hours; and pretreatment levels were
reached again after 72 hours.
The time course found by TUNEL staining showed a
slight variation compared with the histone ELISA (Figure
1B–E). The amount of positive nuclei was already high
after 4 hours (Figure 1C). The number of positive cells
Figure 1. DNA fragmentation after con A injection. DNA fragmentation
of liver cells was either monitored by (A) histone ELISA or (B–E)
TUNEL-Test as described in Materials and Methods. Apoptotic hepato-
cytes by TUNEL-Test are shown (B) before injection, (C) 4 hours after
con A injection, (D) 4 hours after con A injection plus anti-TNF
pretreatment, and (E) after 4 hours when only the carrier solution was
injected. Histone ELISA was performed at all different time points. The
value before treatment of the animals was set to 1, and all other
values were calculated accordingly and expressed as fold activation.
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decreased after 24 hours. Treatment of con A with anti-
TNF antibodies reduced apoptosis (Figures 1A and D).
Translocation, Nuclear Expression, and
DNA Binding of NF-kB
Binding of TNF to TNF receptor 1 may induce
apoptosis and NF-kB activation.8 In the con A model,
DNA fragmentation was first detected 4–8 hours after
con A injection. We therefore studied in vivo nuclear
translocation of NF-kB p65 by immunofluorescence
(Figure 2A, C, E, and G). Already 1 hour after con A
injection, NF-kB was found in the nucleus of hepato-
cytes. An additional increase was observed for up to 4
hours, and NF-kB expression remained high for up to 12
hours, after which nuclear staining of NF-kB p65
decreased (data not shown). At time points later than 48
hours after con A injection, only a weak signal for NF-kB
p65 was found in the nucleus of hepatocytes. The nuclear
translocation of NF-kB p65 was completely blocked 4
hours after con A and anti-TNF administration (Figure
2E).
To assess that the nuclear translocation of NF-kB really
occurred in hepatocytes, double staining was performed
with an anti–cytochrome P450 2D6 antibody (Figure 2B,
D, F, and H). Cells positive for NF-kB in the nucleus also
had a cytoplasmic staining for cytochrome P450 2D6
(Figure 2D). These experiments showed that NF-kB
activation occurred in hepatocytes.
The increase in the nuclear translocation of NF-kB p65
was quantitated by Western blot experiments of nuclear
extracts. A greater than 10-fold increase in nuclear
accumulation of NF-kB p65 was evident 4 hours after
con A injection (Figure 3A). Pretreatment levels were
reached again 96 hours after injection. When the animals
were pretreated with anti-TNF antibodies before con A
injection, only a slight increase was detectable after 2
hours, and no change was found when only the carrier
solution was used (Figure 3B and C). A weaker, but very
similar, time course was found when the nuclear expres-
sion of p50 was tested, showing nuclear translocation
restricted to con A injection (Figure 3, lower panels).
Higher nuclear NF-kB expression correlated with its
DNA binding. In gel shift experiments, an increase in
complex formation was observed for up to 4 hours, and
high-affinity binding lasted from 4 to 12 hours after con
A injection (Figure 4A). This observation was restricted
to T-cell activation after con A injection. Anti-TNF
pretreatment nearly completely blocked complex forma-
tion (Figure 4B), and no specific band appeared after
injection of the buffer control (Figure 4C). The complex
was completely supershifted with an anti-p65 antibody,
whereas anti-p50 only supershifted the lower of the two
bands (Figure 4D). These results indicated that the upper
band most likely consists of a p65 homodimer and the
lower band of a p65/p50 heterodimer.
Figure 2. Enhanced nuclear translocation of NF-kB after con A
injection. Site of NF-kB p65 in liver tissue. Double immunofluores-
cence staining was performed with antibodies directed against NF-kB
(anti-rabbit) and cytochrome P450 2D6 (anti-human). Cy3-conjugated
anti-rabbit and FITC-conjugated anti-human antibodies were used as
secondary antibodies. NF-kB staining was detected with a 615-nm
filter (left panels) and cytochrome P450 2D6 with a 525-nm filter (right
panels). Liver sections are shown (A and B) before treatment, (C and
D) 4 hours after con A injection, (E and F) 4 hours after con A injection
plus anti-TNF treatment, and (G and H) 24 hours after con A injection.
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Activation of JNK, but Not ERK Kinase, Is
Associated With Apoptosis of Hepatocytes
After T-Cell Activation
Cell culture experiments provided evidence that
apoptosis induced by Fas and TNF is associated with




Figure 3. Higher nuclear expression of NF-kB p50 and p65 after con
A–induced T-cell activation in liver cells. Western blot analysis was
performed with liver nuclear extracts and anti-p65 (upper panel) and
anti-p50 (lower panel) antibodies. Animals were either treated with (A)
con A, (B) con A plus anti-TNF, or (C) the carrier solution alone. Nuclear
extracts were used before treatment (lane 1) or at different time
points after injection as indicated. The positions of NF-kB p65 and p50
are indicated. MW, molecular weight.
A B
C D
Figure 4. DNA binding of NF-kB is enhanced after con A injection in
liver nuclei. Liver nuclear extracts (1 mg) were incubated with a
32P-labeled oligonucleotide representing an NF-kB consensus se-
quence. Liver nuclear extracts from mice were either treated with (A)
con A, (B) con A plus anti-TNF, or (C) the carrier solution alone. Nuclear
extracts were used either before injection (lane 1) or at different time
points after treatment. The positions of the bound and free DNA are
marked. (D) Supershift experiments. Liver nuclear extracts were used
before treatment (lane 1) or at 4 hours after con A injection (lanes
2–8). Increasing amounts of anti-p50 (lanes 3–5) or anti-p65 (lanes
6–8) were added to the incubation mix.
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kines are elevated, which are involved in different
signaling pathways.3,5 Thus, in vivo after T-cell stimula-
tion, the situation is more complex. We studied two
MAPK pathways: activation of JNK and ERK.22 In vitro
gel kinase assays were applied to measure the activity of
JNK and ERK after induction of T cell–mediated
apoptosis in hepatocytes.
One hour after con A–induced T-cell activation, JNK
activity exceeded the pretreatment level more than
20-fold (Figure 5A). JNK activity remained high for up
to 4 hours. At later time points, when DNA fragmenta-
tion started, JNK activity clearly decreased, and pretreat-
ment levels were found again 24 hours after con A
injection. Activation of JNK was nearly completely
blocked by pretreatment with anti-TNF antibodies. The
maximal increase (fourfold) was found 4 hours after con A
and anti-TNF treatment. No significant change was
evident when the buffer control was administered.
At the early time points after con A injection, after 2
hours, the increase in JNK was only twofold compared
with the pretreatment level and was not significantly
higher than in animals in which only the carrier solution
was injected. Twelve hours after T-cell stimulation by con
A and anti-TNF treatment, JNK activity peaked and was
fourfold higher than the pretreatment levels. After this
time point JNK activity returned to nearly normal.
The cascade that leads to the activation of ERK 1 1 2
resembles the pathway involved in JNK activation but is
stimulated by different factors. In contrast to JNK, ERK
activity was only slightly increased after con A–induced
T-cell activation (Figure 5B). The increase in ERK
activity was only 2–3-fold and lasted for up to 12 hours.
Even after injection of the carrier solution, ERK activity
increased nearly 2-fold after 2 hours. The increase in ERK
1 1 2 activity, therefore seemed not to be specifically
linked to con A–induced liver damage in contrast to the
results obtained for JNK.
Con A Injection Activates c-Jun Expression
and DNA Binding Via a JNK-Independent
Pathway
Activation of JNK and consecutive phosphoryla-
tion of serine 63 and 73 in the transactivation domain of
c-Jun is associated with increased transcription of c-Jun–
dependent genes.23 Additionally, c-Jun controls its own
transcription by binding to a site in its own promoter.24
We therefore investigated whether JNK activation is
associated with higher c-Jun messenger RNA (mRNA)
levels by using Northern blot analysis. A slight increase
in c-Jun mRNA expression was found already after 1
hour (Figure 6A). A constant, more than 10-fold, increase
was observed for up to 8 hours, after which c-Jun mRNA
levels decreased. Pretreatment levels were reached after
48 hours. After pretreatment with anti-TNF antibodies,
only a slight increase of c-Jun mRNA was evident (Figure
6B). The levels were back to normal 24 hours after
injection, and no change was found when the carrier
solution was injected (Figure 6C).
Because hepatic c-Jun mRNA showed a distinct
increase after con A injection, we studied how its increase
is reflected on the protein level. Western blot analysis of
liver nuclear extracts was performed with an anti–c-Jun
A
B
Figure 5. JNK, not ERK, activation is associated with apoptosis. (A)
Recombinant GST-Jun protein was incubated with 25 mg of liver
nuclear extracts from mice treated with the substrates (control, con A,
and con A 1 anti-TNF) at various time points after injection. Phosphor-
ylation of GST-Jun by extract-derived JNK was measured by incorpora-
tion of [g-32P]ATP as determined by SDS-PAGE and PhosphorImager
analysis. Extracts from the murine fibroblast cell line 3T3 were used
as positive control (1); the same extracts incubated with GST alone
were used as a negative control (2). (B) ERK-1 and ERK-2 proteins
were immunoprecipitated from 25 mg of the same liver nuclear
extracts using a cross-reactive anti–ERK-2 polyclonal antibody. In vitro
kinase reactions were performed on the immune complexes using
recombinant GST-Elk protein as a substrate and [g-32P]ATP as a
phosphodonor. Reactions were subjected to SDS-PAGE and Phos-
phorImager analysis. Extracts from 3T3 cells were used as a positive
control when incubated with GST-ELK (1).
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antibody (Figure 7A). The level of nuclear c-Jun protein
expression was significantly higher already after 1 hour.
Nuclear c-Jun expression increased slightly until 8 hours
and was high for up to 24 hours after con A injection.
c-Jun expression decreased after 24 hours, and pretreat-
ment levels were reached after 96 hours (Figure 7A).
Unexpectedly, nuclear c-Jun expression was high already
2 hours after con A and anti-TNF injection and was
elevated for up to 12 hours (Figure 7B). At later time
points, c-Jun expression was low again. No changes were
found in the control-treated animals (Figure 7C).
To further confirm the differences in c-Jun mRNA and
protein expression, gel shift experiments were performed.
In agreement with Western blot analysis, complex forma-
tion was clearly enhanced 1 hour after con A injection
(Figure 8A). Complex formation increased and was
maximal after 8 hours. No specific complex formation
was observed after 96 hours. Also, after pretreatment
with anti-TNF, an increase in binding was observed after
2 hours and maximal binding was evident at 4 and 12
hours (Figure 8B). Complex formation was comparable to




Figure 6. Higher c-Jun mRNA expression after con A injection. North-
ern blot analysis was performed at different time points after (A) con A
injection and (B) con A plus anti-TNF treatment. (C) Animals treated
with the buffer control. Specific signals were detected with a 32P-




Figure 7. Nuclear c-Jun protein expression is increased after con A
and con A plus anti-TNF treatment. Nuclear proteins derived at
different time points from mice after (A) con A injection and (B) con A
plus anti-TNF treatment and from (C) control-treated animals were
separated on a 10% SDS gel, and Western blot analysis using an
anti–c-Jun antibody was performed. The position of c-Jun is indicated.
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first 12 hours. No complex formation was observed in the
animals in which the carrier solution was injected (Figure
8C). The specificity of the complex that appeared after
con A injection was confirmed by competition studies
with nuclear extracts of animals treated with con A for 8
hours (data not shown). Supershift experiments were also
performed with an anti–c-Jun antibody (Figure 8D),
showing that the complex consisted mainly of c-Jun.
Only a lower band was not supershifted with the
anti–c-Jun antibody, indicating that an additional pro-
tein was present in the complex.
Discussion
Con A injection in mice leads to apoptosis of
hepatocytes. Earlier results showed that con A activates
CD4-positive cells infiltrating into hepatic tissue. Activa-
tion of T cells and mononuclear cells results in the
production and release of various cytokines, e.g., TNF-a
and interferon gamma (IFN-g).2,5,25 Anti-TNF antibod-
ies are able to block liver injury. Therefore, it was
suggested that TNF-a may directly or indirectly be
involved in inducing apoptosis in this model. Recent
experiments showed that both TNF receptors are essen-
tial for inducing liver cell damage in the con A model
because TNF receptors 1 and 2 knockout mice are
protected. Evidence shows that TNF receptor 2 might be
essential in the communication between lymphocytes and
might be involved in the induction of IFN-g.26 The role
of TNF receptor 1 seems more directly involved in
inducing apoptosis of hepatocytes in the con A model.
The aim of this study was to investigate intracellular
pathways that originate at the TNF receptor of hepato-
cytes after con A injection in vivo.
Recent experiments by Hsu et al. suggested that
different signaling cascades are activated through the
cytoplasmic death domain of the TNF receptor 1. These
pathways lead to either nuclear translocation of NF-kB,
activation of JNK, or induction of apoptosis.8,11,12 Our
results show that also in vivo, after con A–mediated
T-cell activation, all three pathways became activated.
Furthermore, anti-TNF treatment blocked activation of
NF-kB translocation, JNK activation, and apoptosis.
These results were obtained using whole liver tissue.
Immunofluorescence studies indicated that most of the
activation may occur in hepatocytes. However, some of
the activation might have occurred in the nonparenchy-
mal cells.
The TNF receptor mediates JNK activation via a
signal transduction pathway consisting of the sequential
activation of distinct protein kinases.27 Recently, the
activation of JNK was linked to apoptosis.19,20 Mutant
forms of the kinases involved in this pathway acting as
dominant negative repressors of JNK activation pre-
vented the induction of apoptosis in this in vitro
system.28 However, there is no experimental proof that
this regulation is also crucial in more complex systems. In
contrast, recent experiments provided strong evidence
A B
C D
Figure 8. Higher DNA binding of c-Jun after con A and con A plus
anti-TNF treatment. Liver nuclear extracts (1 mg) were incubated with a
32P-labeled oligonucleotide representing the AP1 consensus se-
quence. Liver nuclear extracts from mice were either treated with (A)
con A, (B) con A plus anti-TNF, or (C) control buffer. Nuclear extracts
were used either before injection (lane 1) or at different time points
after treatment. The positions of the bound and free DNA are marked.
(D) Supershift experiments. Liver nuclear extracts were used before
treatment (lane 1) or at 8 hours after con A injection (lanes 2–6).
Increasing amounts of anti-c-Jun (lanes 3–6) were added to the
incubation mix.
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that the pathways leading to JNK activation and apopto-
sis can be dissected from each other. These experiments
also indicated that JNK is not a direct regulator of
apoptosis because blocking of the JNK pathway did not
alter induction of apoptosis.11
Maximal activation of JNK after con A injection was
found very early, after 1 hour, following con A–induced
T-cell activation. In contrast, the beginning of DNA
fragmentation can first be observed after 4 hours and is
maximal after 8 hours. The time course of JNK activation
in vivo does not argue against an involvement of JNK in
triggering apoptotic processes. At later time points,
however, when DNA fragmentation is most prominent in
vivo, JNK activity is low again. These results thus show
that JNK is at least not required to maintain DNA
fragmentation in hepatocytes.
Several cytokines become secreted into the plasma after
con A injection, which in turn lead to the induction of
different intracellular signal transduction cascades in
hepatocytes. As an example for one of these cascades,
ERK 1 1 2 was studied. The pathway leading to ERK
1 1 2 activation is closely related to the pathway
controlling JNK activation.20 However, activation of
ERK 1 1 2 seems, in contrast to the results obtained
for JNK, not related to the events found after con
A–mediated liver damage.
After con A injection, high levels of the transcription
factor c-Jun, which is the direct substrate of JNK, have
been found at time points when DNA fragmentation has
not yet been started. c-Jun might play a role in inducing
the apoptotic processes observed at later time points.
Earlier experiments also showed that a dominant negative
form of c-Jun (TAM 77) is able to block apoptosis in
U 937 cells.29 However, blockage of the TNF action by
using an anti-TNF antibody shows that the close link
between c-Jun and induction of apoptosis is not as
evident in con A–induced apoptosis. Despite anti-TNF
treatment, c-Jun is highly expressed in the nucleus and
shows high DNA binding, although no apoptosis occurs.
Expression of c-Jun therefore seems unrelated to apopto-
sis in hepatocytes.
The signals that regulate c-Jun expression after con A
injection and anti-TNF pretreatment are unknown. How-
ever, protein expression of c-Jun after con A injection
seems to be mainly controlled on a posttranscriptional
level, because an increase in c-Jun mRNA level was found
after the increase in c-Jun protein expression. A pathway
activated by one of the other cytokines may likely have
c-Jun as a target, possibly leading to either its high
nuclear translocation or protein stabilization.
After con A injection also nuclear translocation of
NF-kB is controlled in a TNF-dependent manner. In
contrast to JNK activation, which was already most
prominent after 1 hour, nuclear translocation of NF-kB
increased until 4–8 hours after con A injection. Earlier
studies showed that NF-kB is able to prevent apoptosis in
different cell types11,30–33 and may have a similar function
in hepatocytes. Therefore, differences in the activation
kinetics of TNF-dependent signal transduction cascades
might be responsible for the decision toward apoptosis or
NF-kB nuclear translocation. Maximal activation of
DNA fragmentation and nuclear NF-kB translocation
was found at nearly the same time points. Therefore, the
intracellular cascades that induce apoptosis are activated
before that time point, and NF-kB with its prolonged
kinetic is unable to prevent apoptosis and liver injury.
Besides its possible involvement in the prevention of
apoptosis, earlier studies showed that NF-kB is associated
with cell cycle progression in hepatocytes during liver
regeneration.34 Knockout mice lacking the Rel A compo-
nent of NF-kB have a defect in normal liver develop-
ment.35 NF-kB thus seems crucial for events that induce
cell proliferation and thereby repair of the liver. After con
A–induced T cell–mediated apoptosis and an increase in
aminotransferase levels, the liver enters the cell cycle after
24 hours and normal liver function is reconstituted (T.
Rakemann and C. Trautwein, unpublished results). TNF-
dependent signals may have two different functions after
con A–induced T-cell activation. While inducing apopto-
sis via FADD-dependent mechanisms, the receptor acti-
vates pathways via TRAF2 and RIP, which are important
to reconstitute the organ and to establish normal liver
function.
The mechanisms that control whether apoptosis or
NF-kB activation is the more prominent signal at TNF
recptor 1 are not yet defined. Additional signals may be
crucial for influencing the balance in a certain direction.
Because several cytokines are secreted early during this
process, they could synergistically trigger the pathways
that initiate apoptosis. Recent studies of Küsters et al.25
indicate that, in addition to TNF, IFN-g is also critical
for controlling apoptosis after con A injection. They
showed that anti–IFN-g treatment prevented hepato-
cytes from apoptosis after con A–induced T-cell activa-
tion. Lower TNF-a levels were found after anti–IFN-g
pretreatment. However, addition of TNF-a, to substitute
its decrease after anti-IFN treatment, is not sufficient to
induce apoptosis. There is no clear evidence that IFN-g
induces apoptosis after binding to its receptor. It is more
likely that IFN-g modulates the pathways that are
activated after TNF-TNF receptor 1 binding. IFN-g
blocks cell proliferation via Stat1.36 Therefore, high
IFN-g levels directly counteract the known effects of
NF-kB on cell proliferation and possibly also other
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undefined target genes. These results indicate that fur-
ther studies can directly address the question how Stat1
may interfere with cell cycle control and thus trigger
apoptosis.
Fas also induces apoptosis after binding to its li-
gand.37,38 Both Fas and TNF receptor 1 are expressed on
hepatocytes1,4 and use the same intracellular molecule,
FADD/MORT1, which links their activation to apopto-
sis.39 Additional studies using this animal model should
help to develop new therapeutic options to prevent
FADD-dependent apoptosis of hepatocytes, which seems
also crucial during immune-mediated fulminant hepatic
failure in humans.
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